Iron deficiency anemia

Iron deficiency anemia
Name	Iron deficiency anemia
Field	Hematology
Synonyms	Iron-deficiency anaemia

Iron deficiency anemia is a common hematologic condition characterized by reduced hemoglobin concentration due to insufficient iron for erythropoiesis. It affects diverse populations worldwide and intersects with global health initiatives, maternal care programs, pediatric services, and public health surveillance. Clinical management often involves collaboration among specialists in hematology, obstetrics, pediatrics, and infectious disease.

Overview

Iron deficiency anemia is a disorder of red blood cell production found across settings such as World Health Organization, Centers for Disease Control and Prevention, United Nations Children's Fund, Bill & Melinda Gates Foundation, and national ministries of health. Epidemiologic studies from Global Burden of Disease and population surveys conducted by Demographic and Health Surveys have informed policy by agencies including USAID and European Centre for Disease Prevention and Control. Major clinical guidelines published by bodies such as American Society of Hematology, British Society for Haematology, Royal College of Obstetricians and Gynaecologists, and World Health Organization frame diagnostic thresholds and treatment algorithms.

Signs and symptoms

Patients often present with fatigue, pallor, and exertional dyspnea noted in clinical encounters at institutions like Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, and community clinics associated with Partners In Health. Other reported features include koilonychia, pica, and restless legs syndrome observed in case series from centers such as Karolinska Institute and Imperial College London. In pregnant people managed by perinatal services at Kaiser Permanente, signs may complicate obstetric outcomes tracked by databases like National Perinatal Epidemiology Unit. Severe presentations requiring transfusion are seen in tertiary centers including Mount Sinai Health System and UCSF Medical Center.

Causes and risk factors

Common etiologies include chronic blood loss from gastrointestinal sources identified in workups at Mayo Clinic and Johns Hopkins Hospital, nutritional insufficiency highlighted in programs by UNICEF and World Food Programme, and increased physiologic demand during pregnancy monitored by Royal College of Obstetricians and Gynaecologists. Parasitic infections such as hookworm described in reports from Centers for Disease Control and Prevention and endemic control programs run by World Health Organization contribute in tropical regions studied by London School of Hygiene & Tropical Medicine. Malabsorption syndromes evaluated at centers like Cleveland Clinic and Mount Sinai Health System (for example, celiac disease) and surgical causes including procedures at institutions such as Mayo Clinic are additional risk factors. Demographic and socioeconomic determinants are documented in analyses by World Bank, United Nations, and national health agencies like NHS England.

Pathophysiology

Iron homeostasis concepts are elaborated in research from universities like Harvard University, Stanford University, University of Oxford, University of Cambridge, and institutes such as National Institutes of Health. Hepcidin regulation, ferroportin-mediated export, and erythropoietin-driven marrow responses have been detailed in studies from European Hematology Association and journals associated with American Society of Hematology. Molecular defects in iron transport and storage are topics of investigation at genetics centers including Broad Institute and Wellcome Trust Sanger Institute. Pathways linking chronic inflammation from infections like malaria studied by Centers for Disease Control and Prevention and autoimmune disorders treated at Mayo Clinic alter iron distribution and contribute to anemia of chronic disease distinctions developed by American Association for Clinical Chemistry researchers.

Diagnosis

Diagnostic approaches follow protocols from American Society for Clinical Pathology, British Society for Haematology, and laboratory reference standards used at institutions such as Quest Diagnostics, LabCorp, Mayo Clinic Laboratories, Johns Hopkins Hospital, and Massachusetts General Hospital. Common tests include complete blood count, serum ferritin, transferrin saturation, and reticulocyte index; additional imaging and endoscopy may involve centers like Cleveland Clinic and Mount Sinai Health System. Screening guidelines from World Health Organization and national panels guide case-finding in antenatal clinics affiliated with NHS England and public health programs by Centers for Disease Control and Prevention.

Prevention and screening

Population-level measures are promoted by World Health Organization, UNICEF, World Food Programme, Food and Agriculture Organization, and national ministries of health, including iron fortification programs modeled on initiatives in United Kingdom, United States, and Chile. Antenatal screening protocols recommended by Royal College of Obstetricians and Gynaecologists, American College of Obstetricians and Gynecologists, and World Health Organization aim to identify and treat pregnant people early. School-based screening and supplementation programs have been implemented in districts supported by UNICEF and evaluated in trials from universities such as University of São Paulo and University of Melbourne.

Management and prognosis

Management strategies are outlined in practice guidelines from American Society of Hematology, British Society for Haematology, World Health Organization, and specialist groups at Johns Hopkins Hospital and Mayo Clinic. First-line therapy typically includes oral iron formulations used in ambulatory care across systems such as NHS England and Kaiser Permanente; intravenous iron preparations are administered in centers including Cleveland Clinic and Mount Sinai Health System for refractory cases. Transfusion and referral to hematology services at tertiary centers like Massachusetts General Hospital are reserved for severe or unstable patients. Prognosis is generally favorable with treatment, as reported in cohort studies from Global Burden of Disease, National Institute for Health and Care Excellence, and long-term follow-up programs at Brigham and Women's Hospital.

Category:Hematology